# Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation

> **NCT02396251** · NA · TERMINATED · sponsor: **Galderma R&D** · enrollment: 48 (actual)

## Conditions studied

- Facial Tissue Augmentation

## Interventions

- **DEVICE:** HA experimental
- **DEVICE:** HA comparator

## Key facts

- **NCT ID:** NCT02396251
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02-28
- **Primary completion:** 2016-12-19
- **Final completion:** 2017-11-14
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Sponsor business reasons
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02396251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02396251, "Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02396251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*